Prosight Management

Prosight Management as of March 31, 2022

Portfolio Holdings for Prosight Management

Prosight Management holds 32 positions in its portfolio as reported in the March 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Galapagos Nv Spon Adr (GLPG) 15.0 $23M 374k 62.02
Prothena Corp SHS (PRTA) 13.4 $21M 567k 36.57
Albireo Pharma 9.2 $14M 480k 29.83
Galapagos Nv Call Call Option 7.8 $12M 195k 62.02
Charles River Laboratories (CRL) 5.8 $8.9M 32k 283.97
Kalvista Pharmaceuticals (KALV) 5.6 $8.7M 589k 14.74
Cue Biopharma (CUE) 4.8 $7.4M 1.5M 4.88
Aldeyra Therapeutics (ALDX) 4.0 $6.2M 1.4M 4.45
Meiragtx Holdings (MGTX) 3.4 $5.3M 381k 13.85
Kezar Life Sciences 3.2 $5.0M 300k 16.62
Convey Hldg Parent 3.2 $4.9M 748k 6.54
Alnylam Pharmaceuticals (ALNY) 2.4 $3.7M 23k 163.28
Agilon Health (AGL) 2.3 $3.5M 140k 25.35
Shattuck Labs (STTK) 2.2 $3.4M 799k 4.26
Rocket Pharmaceuticals (RCKT) 2.1 $3.2M 203k 15.86
Quidel Corporation 1.9 $2.9M 26k 112.44
Encompass Health Corp (EHC) 1.8 $2.8M 40k 71.10
Oscar Health Cl A (OSCR) 1.5 $2.4M 238k 9.97
Accolade (ACCD) 1.4 $2.2M 124k 17.56
Select Medical Holdings Corporation (SEM) 1.4 $2.2M 91k 23.99
Crispr Therapeutics Namen Akt (CRSP) 1.4 $2.1M 34k 62.76
Inmode SHS (INMD) 1.2 $1.8M 50k 36.92
Mirum Pharmaceuticals (MIRM) 1.1 $1.6M 74k 22.02
Globus Med Cl A (GMED) 0.9 $1.3M 18k 73.78
Silverback Therapeutics (SPRY) 0.7 $1.1M 325k 3.51
Neogenomics Com New (NEO) 0.5 $772k 64k 12.15
Organon & Co Put Put Option 0.5 $699k 20k 34.95
Cognition Therapeutics (CGTX) 0.4 $660k 240k 2.75
Proqr Thrapeutics N V Shs Euro (PRQR) 0.3 $542k 599k 0.90
Sio Gene Therapies Common 0.3 $449k 670k 0.67
Iovance Biotherapeutics (IOVA) 0.2 $333k 20k 16.65
Cymabay Therapeutics 0.2 $292k 94k 3.11